Literature DB >> 7264720

Metabolic effects of unilateral lesion of the substantia nigra.

G F Wooten, R C Collins.   

Abstract

Regional brain glucose utilization following unilateral lesion of the substantia nigra in rat was studied by [14C]-2-deoxyglucose autoradiography. Substantia nigra lesions were performed by perinigral injections of 6-hydroxydopamine (6-OHDA) . HBr, 6 microgram, in rats pretreated 30 min earlier with desmethylimipramine (DMI), 25 mg/kg, subcutaneously. The lesion produced extensive destruction of the ipsilateral substantia nigra pars compacta and a greater than 99% reduction in dopamine concentration in the ipsilateral striatum. Pretreatment with DMI prevented any reduction in the concentration of norepinephrine in ipsilateral forebrain structures. Glucose utilization was increased in the ipsilateral globus pallidus at 11, 21, 53, and 104 days after substantia nigra lesion with the largest increase (about 140% of control) occurring at 21 days post-lesion. In addition, glucose utilization in ipsilateral lateral habenular nucleus was increased at each of the above time points. No changes in glucose utilization were noted in frontal cortex, striatum, subthalamic nucleus, entopeduncularis, or ventral tier nuclei of the thalamus. These results suggest that lesion of the substantia nigra with depletion of striatal dopamine content results in disinhibition of some striatal, and perhaps olfactory cortical, efferents producing increased metabolism and glucose utilization in terminal fields within the globus pallidus and lateral habenular nucleus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7264720      PMCID: PMC6564122     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  21 in total

1.  Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.

Authors:  K Elisabet Ohlin; Irene Sebastianutto; Chris E Adkins; Cornelia Lundblad; Paul R Lockman; M Angela Cenci
Journal:  Neuroimage       Date:  2012-03-03       Impact factor: 6.556

Review 2.  PET and movement disorders.

Authors:  D J Brooks; R S Frackowiak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

3.  Metabolic mapping of the effects of the antidepressant fluoxetine on the brains of congenitally helpless rats.

Authors:  Jason Shumake; Rene A Colorado; Douglas W Barrett; F Gonzalez-Lima
Journal:  Brain Res       Date:  2010-05-12       Impact factor: 3.252

Review 4.  Reinforcement learning, conditioning, and the brain: Successes and challenges.

Authors:  Tiago V Maia
Journal:  Cogn Affect Behav Neurosci       Date:  2009-12       Impact factor: 3.282

Review 5.  The determination of the local cerebral glucose utilization with the 2-deoxyglucose method.

Authors:  A Wree; A Schleicher
Journal:  Histochemistry       Date:  1988

6.  Regional cerebral glucose utilization during morphine withdrawal in the rat.

Authors:  G F Wooten; P DiStefano; R C Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects.

Authors:  Gregor Hasler; Stephen Fromm; Paul J Carlson; David A Luckenbaugh; Tracy Waldeck; Marilla Geraci; Jonathan P Roiser; Alexander Neumeister; Noah Meyers; Dennis S Charney; Wayne C Drevets
Journal:  Arch Gen Psychiatry       Date:  2008-05

8.  PET studies of cerebral metabolism in Parkinson disease.

Authors:  William J Powers
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

9.  Functional role for vasoactive intestinal polypeptide in the caudate nucleus: a 2-deoxy[14C]glucose investigation.

Authors:  J McCulloch; P A Kelly; R Uddman; L Edvinsson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

10.  Regional, kinetic [(18)F]FDG PET imaging of a unilateral Parkinsonian animal model.

Authors:  Matthew D Silva; Charles Glaus; Jacob Y Hesterman; Jack Hoppin; Geraldine Hill Della Puppa; Timothy Kazules; Kelly M Orcutt; Mary Germino; David Immke; Silke Miller
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.